Check out the new KDIGO IgAN/IgAV Guideline Key Takeaways! IgAN: kdigo.co/KDIGO-IgAN-G... IgAV: kdigo.co/KDIGO-Guidel... These resources are designed to provide clinicians with quick and practical access to the most important points from the new KDIGO guideline on managing #IgAN and #IgAV.

The @kdigo.org IgA guidelines published www.kidney-international.org/article/S008... We discussed them with Jon Barratt here: youtu.be/OChs5BcTEGE?... on #NephGR

KDIGO is pleased to announce the publication of the 2025 IgA Nephropathy (#IgAN) and IgA Vasculitis (#IgAV) Guideline, along with its Executive Summary in @kidneyint.bsky.social. Download: kdigo.co/KDIGO-IgAN-I... Read in KI: kdigo.co/KDIGO-IgAN-I... Exec Summary: kdigo.co/IgAN-IgAV-Gu...

Check out the September issue of KDIGO Direct for the latest updates from KDIGO: kdigo.co/KDIGO-Direct... - The KDIGO IgAN Guideline is almost here! - Highlights from global meetings - New KDIGO Conversations in Nephrology Podcast series - Upcoming activities, new resources, and more

🧰 The ISN Early CKD Detection Toolbox helps you design and sustain screening programs. With @kdigo.org, it links key steps to practical, evidence-based resources—adaptable to all settings. ➡️ http://lite.spr.ly/6...

Check out the August issue of KDIGO Direct for the latest news and updates from KDIGO: kdigo.co/KDIGO-Direct...

PKD Foundation Center of Excellence, Columbia University Medical Center, is hosting an educational event on PKD Awareness Day! Join on Thursday, September 4 for a free virtual event designed to educate, empower, and connect the PKD community. Learn more: eventleaf.com/e/ADPKD-9-2025

The KDIGO APOL1 Kidney Disease Conference Report is now available in @kidneyint.bsky.social! Co-chaired by Dr. Akinlolu Ojo (US) & Dr. Ifeoma Ulasi (NG) in Accra, Ghana, the meeting united global experts to address the urgent, inequitable burden of #APOL1. Read the report: kdigo.co/APOL1-Confer...

Happening today at 2:30pm ET: A vital CME session on #IgAN care, covering mechanisms to management. Proud to partner with @kdigo.org & @nordrare.bsky.social Don’t miss it 🔗 bit.ly/44ZyEkg #Nephrology #CKD #MedicalEducation #CME #KDIGO #MedLive

What is the target intact PTH level in patients with CKD who are not on dialysis? from @kdigo.org #Nephpearls #CKDMBD #NephSky 👉 kdigo.org/guidelines/c...

🙏🏻😊 Grateful for this opportunity to work alongside global experts @kdigo.org to advance healthcare technology and AI in kidney care. #Nephrology 🙏🏻 in the upcoming Controversies Conference on #AI Technological Advancements to Support Guideline-Directed Care in Madrid, Spain 🇪🇸 2025 #KDIGO

Do you treat #IgAN? Check out this free [email protected] #CME credited webinar about why #proteinuria reduction matters, how #KDIGO guidelines shape care, and what new therapies targeting endothelin-1 and angiotensin-2 mean for your patients: bit.ly/4eIKu6N

Check out the new KDIGO Direct for the latest updates from KDIGO: kdigo.co/KDIGO-Direct... In this issue: - KDIGO Early Career Mentorship Program - CKD Prevention Conference Report - B Cell Controversies Conference - New KDIGO Guideline Global Survey - Upcoming activities & new resources

Plenary recordings from the recent KDIGO B Cell Controversies Conference are now available! 🎥 kdigo.co/B-Cell-Contr... Topics include B cell therapy in podocytopathies, emerging treatment strategies in lupus nephritis, and targeting B cells in IgAN, as well as a compelling patient panel.

🌍 Take the KDIGO Guideline Global Survey! KDIGO wants to learn how clinicians use our guidelines, where they fall short, and what tools or formats would improve daily practice. Your input will help shape better guidance in kidney care. We truly value your perspective. 📝 kdigo.co/Global-Guide...

Missed our webinar, “Managing ADPKD: Treatments, Lifestyle, & Living Well?” The full recording is now available: youtu.be/l0gd8ID94vo

Resistant Membranous Nephropathy: Treatment approach from @kdigo.org #Nephpearls #NephSky 👉 kdigo.org/guidelines/gd/

What does #IgAN care look like in a region where it’s common? Dr. Hong Zhang joins former KDIGO CEO John Davis to explore the burden of IgAN in Asia, differences in disease presentation, breakthrough therapies, and how precision medicine is changing treatment. Watch now: kdigo.co/Asian-Perspe...

Preventing chronic kidney disease and maintaining kidney health: conclusions from @kdigo.org Controversies Conference ca. 2025 #Nephpearls #NephSky 👉🏼 pubmed.ncbi.nlm.nih.gov/40536455/

T0e: #NephJC Looking at the previous infographic, and at the pace nephrology is moving further, we might soon need an update of the @kdigo.org CKD guideline www.nephjc.com/news/...#NephJC

KDIGO is pleased to share the newly published report from its Controversies Conference on Preventing #CKD and Maintaining Kidney Health, now available in press in Kidney International (KI). 📄 Download the report: kdigo.co/2025-CKD-Pre... 📘 Read in KI: kdigo.co/KDIGO-2025-C...

Check out the June issue of KDIGO Direct: kdigo.co/KDIGO-Direct... In this issue: - Introducing the KDIGO Guideline Methodology Fellows! - Women and Kidney Health Controversies Conference Report published - Upcoming activities - New resources, including expert video and new on-demand #CME programs

Get up to speed on new strategies for diagnosing and treating IgA nephropathy in this expert-led session. A must-watch for anyone focused on kidney health. 🎥 Tap in and learn from leading #nephrology voices: 👉https://bit.ly/4097ohk #CME ##KidneyHealth #MedicalEducation #ContinuingEducation

The KDIGO Women and Kidney Health Controversies Conference Report is now available in Kidney International! The report addresses how sex and gender shape kidney health across the lifespan, with a special focus on reproductive health and care equity. Read the report: kdigo.co/Women-and-Ki...

Coming soon: A focused session on IgA Nephropathy (#IgAN) exploring the latest in diagnosis and treatment, including real-world applications. Presented in partnership with @kdigo.org join us to deepen your understanding: bit.ly/43FKJeQ #CME #KidneyHealth #MedEd

Join us June 9 at 1:00 PM ET for a KDIGO–Medlive webinar on tackling complement-mediated glomerular diseases like #C3G. Register: kdigo.co/Medlive-KDIG... Dr. Richard Lafayette and Dr. Pietro Canetta will discuss the burden of disease, current treatment limitations and the promise of new therapies.

Join us for the next @theisn.org-KDIGO webinar: "Women and Kidney Health: Insights from the KDIGO Controversies Conference" on May 29 at 11:00 EST/5:00 pm CEST. Register: kdigo.co/Women-Kidney... Learn how sex and gender influence kidney disease risk, outcomes, and research priorities.

𝗦𝗔𝗩𝗘 𝗧𝗛𝗘 𝗗𝗔𝗧𝗘 for the next [email protected]‬ Webinar: "Women and Kidney Health: Insights from the KDIGO Controversies Conference." 🗣️ Sofia Ahmed, Giorgina Piccoli 👥 Christina Wyatt 🗓️ May 29 🕑 5:00 pm CEST 🔗 Free registration: http://lite.spr.ly/6...

New @kdigo.org guideline on autosomal dominant polycystic kidney disease (ADPKD) emphasizes lifestyle management and shared decision-making for this disease that affects up to 12 million people worldwide. bit.ly/KN1705-02 #ASNKidneyNews

Check out the latest KDIGO Direct: kdigo.co/KDIGO-Direct... In this issue: 📗 Nephrotic Syndrome in Children GL publishes 📢 Dr. Wanner elected KDIGO Co-Chair 💔 KDIGO mourns Dr. Rinaldo Bellomo 🌍 KDIGO convenes Green Dialysis Conference 🏛️ KDIGO at #ERA25 🎥 New resources on #ADPKD, #C3G, #CKM & #IgAN

The ADPKD @kdigo.org guideline episode of @freelyfiltered.bsky.social www.nephjc.com/freelyfilter... Joel, Nayan, AC, with Sophia Ambruso coining a new word for posting here (bleat!) And Charles Edelstein dropping lot of wisdom + @rheaultm.bsky.social with a cameo #NephSky

Today is #IgANAwarenessDay! KDIGO is joining clinicians, patients, and researchers worldwide in raising awareness of IgA Nephropathy ( #IgAN ). Check out KDIGO IgAN resources below, and stay tuned for the KDIGO 2025 IgAN Guideline—coming this fall!

1/10 We were delighted to discuss the first ever @KDIGO ADPKD guidelines this March! So satisfied with the chat itself that we forgot to post the #TenPostsNephJC 😉 So here we are! Better late than never.#NephJC kdigo.org/guidelines/a...

🚨New @acr-journals.bsky.social guidelines for lupus nephritis #medsky #nephsky Any difference compared with @kdigo.org guideline? ⭐I'll start: in refractory LN- antiCD20 MAbs rheumatology.org/lupus-guidel...

Do you prescribe SGLT2 inhibitors (SGLT2i) for patients with ADPKD? #Nephpearls #AskRenal #NephSky ❤️ LIKE for YES (and why?) ❌ X for NO (and why?) 👉 pubmed.ncbi.nlm.nih.gov/39099568/

SGLT2 inhibitor (SGLT2i) Cold 🥶 Map: Indications for SGLT2i in CKD/ Albuminuria/ Type 2 Diabetes (T2D)/ Heart Failure (HFrEF, HFmrEF, HFpEF) from @theisn.org @kdigo.org @renalphysicians.bsky.social @aspcardio.bsky.social #Nephpearls #Cardiorenal #NephSky 👉 www.theisn.org/initiatives/...

Use of SGLT2 inhibitors (SGLT2i) in ADPKD is not "presently" recommended, because people with ADPKD have been excluded from the clinical trials; thus, its safety has not been evaluated (from @kdigo.org) #Nephpearls #NephSky 👉 kdigo.org/guidelines/a...

We are pleased to announce that the KDIGO Executive Committee has elected Christoph Wanner to serve as the organization’s next Co-Chair, beginning January 1, 2026. He will join Co-Chair Morgan Grams, MD, and succeed Michel Jadoul, MD. Read the news release: lnkd.in/dzJWXeVX

Guiding Practice Through the Latest @kdigo.org Guidelines on ADPKD #Nephpearls #NephSky www.medpagetoday.com/meetingcover...

GLP-1 receptor agonists and other incretin mimetics for #diabetes and #chronickidneydisease — a #KDIGO commentary doi.org/10.1016/j.kint.2024.12.019 #OpenAccess #KIEditorial #GLP-1RA @kdigo.org

Snapshot of IgA Nephropathy (IgAN) Pathophysiology: Mechanistic Targets 🎯 of Potential Novel Therapies from @kdigo.org #Nephpearls #NephSky 👉 kdigo.org/guidelines/i...

Holistic approach to Non-diabetic CKD and Diabetic Kidney Disease (CKD) from @kdigo.org #Nephpearls #NephSky 👉 kdigo.org/guidelines/c... 👉 kdigo.org/guidelines/d...

8️⃣ Cardio-Kidney-Metabolic Initiative: Since 2022, ISN has united nephrologists and cardiologists to address care gaps and develop toolkits that support clinicians managing cardio-kidney-metabolic conditions: www.theisn.org/initiatives/... @kdigo.org

Recommended approach for initial therapy of active class III/ IV Lupus Nephritis from @kdigo.org #Nephpearls #NephSky 👉 shop.lww.com/Handbook-of-...

Building the future of sustainable dialysis starts with bold ideas and global collaboration — and that spirit was clear at the KDIGO Controversies Conference on Green Dialysis. Thanks to the incredible experts, clinicians, and advocates who made this such an impactful meeting! #greendialysis

⬇️ carbon dialysis👣. Did you know that if healthcare were a country, it would be the 5th largest polluter in the 🗺️ ? Initiatives like @theisn.org #GreenK & @kdigo.org Controversies Conference on #GreenDialysis are helping us understand the problem & 🔎sustainable solutions. ♻️

KDIGO is excited to see AHA spotlight the central role of the kidney in CKM syndrome and the critical importance of testing both GFR and albuminuria. Great to see the KDIGO Heat Map featured! #CKMsyndrome #CKM #HeartKidney

We are pleased to announce the publication of the KDIGO 2025 Guideline for Nephrotic Syndrome in Children—an update to Chapter 4 of the KDIGO 2021 Glomerular Diseases Guideline. 📄 Read in @kidneyint.bsky.social: kdigo.co/Nephrotic-Sy... 🧵More below ⬇️

➡️ Executive summary of the 2025 Update to the @kdigo.org Nephrotic SyndromeE in Children Gduideline www.kidney-internati...

➡️ GLP-1 receptor agonists and other incretin mimetics for diabetes and chronic kidney disease –a @kdigo.org commentary www.kidney-internati...